Published in J Am Acad Dermatol on December 01, 2005
Granuloma faciale with extrafacial involvement and response to tacrolimus. J Cutan Aesthet Surg (2012) 1.18
Successful treatment of granuloma faciale with topical tacrolimus: a case report and immunohistochemical study. Case Rep Dermatol (2012) 0.95
Photoletter to the editor: Dermoscopy of granuloma faciale. J Dermatol Case Rep (2012) 0.75
The interaction of inflammatory cells in granuloma faciale. Dermatol Reports (2010) 0.75
Granuloma faciale. Indian Dermatol Online J (2016) 0.75
Granuloma faciale: a good therapeutic response with the use of topical tacrolimus. An Bras Dermatol (2015) 0.75
Granuloma faciale. Indian Dermatol Online J (2016) 0.75
Granuloma faciale: clinical, morphological and immunohistochemical aspects in a series of 10 patients. An Bras Dermatol (2017) 0.75
Granuloma faciale: A master masquerader? Indian Dermatol Online J (2016) 0.75
Complete Clearance of Resistant Granuloma Faciale With Pulsed Dye Laser After Pre-treatment With Mometasone and Tacrolimus. J Lasers Med Sci (2017) 0.75
WHO-EORTC classification for cutaneous lymphomas. Blood (2005) 12.14
Application of a filtration- and isolation-by-size technique for the detection of circulating tumor cells in cutaneous melanoma. J Invest Dermatol (2010) 3.26
Cutaneous side-effects of kinase inhibitors and blocking antibodies. Lancet Oncol (2005) 2.85
Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases. Blood (2007) 2.82
IL-10 produced by activated human B cells regulates CD4(+) T-cell activation in vitro. Eur J Immunol (2010) 2.67
Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells. J Allergy Clin Immunol (2004) 2.33
Cardiovascular involvement, an overlooked feature of Erdheim-Chester disease: report of 6 new cases and a literature review. Medicine (Baltimore) (2004) 2.27
Keratoacanthomas and squamous cell carcinomas in patients receiving sorafenib. J Clin Oncol (2009) 2.16
Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): a review. Am J Clin Pathol (2005) 2.15
Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases. Arch Dermatol (2007) 2.00
The clinical spectrum and therapeutic management of hypocomplementemic urticarial vasculitis: data from a French nationwide study of fifty-seven patients. Arthritis Rheumatol (2015) 1.98
ERK and PDE4 cooperate to induce RAF isoform switching in melanoma. Nat Struct Mol Biol (2011) 1.85
Granulomatous mycosis fungoides and granulomatous slack skin: a multicenter study of the Cutaneous Lymphoma Histopathology Task Force Group of the European Organization For Research and Treatment of Cancer (EORTC). Arch Dermatol (2008) 1.78
A new device for rapid isolation by size and characterization of rare circulating tumor cells. Anticancer Res (2011) 1.74
Adverse cutaneous reactions to imatinib (STI571) in Philadelphia chromosome-positive leukemias: a prospective study of 54 patients. J Am Acad Dermatol (2003) 1.74
Neutrophilic urticarial dermatosis: a variant of neutrophilic urticaria strongly associated with systemic disease. Report of 9 new cases and review of the literature. Medicine (Baltimore) (2009) 1.72
Skin tumors induced by sorafenib; paradoxic RAS-RAF pathway activation and oncogenic mutations of HRAS, TP53, and TGFBR1. Clin Cancer Res (2011) 1.52
WHO/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects. J Cutan Pathol (2005) 1.51
Prospective study of the cutaneous adverse effects of sorafenib, a novel multikinase inhibitor. Arch Dermatol (2008) 1.49
Membrane expression of NK receptors CD160 and CD158k contributes to delineate a unique CD4+ T-lymphocyte subset in normal and mycosis fungoides skin. Cytometry A (2014) 1.48
Psoriasis induced by tumor necrosis factor-alpha antagonist therapy: a case series. J Rheumatol (2006) 1.46
Scleromyxedema: a multicenter study of characteristics, comorbidities, course, and therapy in 30 patients. J Am Acad Dermatol (2013) 1.44
Circulating natural killer lymphocytes are potential cytotoxic effectors against autologous malignant cells in sezary syndrome patients. J Invest Dermatol (2005) 1.44
Dermatologic symptoms associated with the multikinase inhibitor sorafenib. J Am Acad Dermatol (2008) 1.33
Toxic epidermal necrolysis, DRESS, AGEP: do overlap cases exist? Orphanet J Rare Dis (2012) 1.32
Drug specific cytotoxic T-cells in the skin lesions of a patient with toxic epidermal necrolysis. J Invest Dermatol (2002) 1.32
SC5 mAb represents a unique tool for the detection of extracellular vimentin as a specific marker of Sezary cells. J Immunol (2006) 1.21
Molecular profiling of malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1, based on large-scale real-time RT-PCR. Mol Cancer (2004) 1.19
Inter-observer variation in the histopathological diagnosis of clinically suspicious pigmented skin lesions. J Pathol (2002) 1.17
Ipilimumab-induced acute severe colitis treated by infliximab. Melanoma Res (2013) 1.16
Ocular manifestations in the inherited DNA repair disorders. Surv Ophthalmol (2003) 1.16
Characterization of a novel human type II epithelial keratin K1b, specifically expressed in eccrine sweat glands. J Invest Dermatol (2005) 1.15
Cytotoxic/natural killer cell cutaneous lymphomas. Report of EORTC Cutaneous Lymphoma Task Force Workshop. Cancer (2003) 1.15
Evaluation of the potential role of cytokines in toxic epidermal necrolysis. J Invest Dermatol (2004) 1.09
CD56-positive haematological neoplasms of the skin: a multicentre study of the Cutaneous Lymphoma Project Group of the European Organisation for Research and Treatment of Cancer. J Clin Pathol (2006) 1.08
Novel and recurrent germline and somatic mutations in a cohort of 67 patients from 48 families with Brooke-Spiegler syndrome including the phenotypic variant of multiple familial trichoepitheliomas and correlation with the histopathologic findings in 379 biopsy specimens. Am J Dermatopathol (2013) 1.08
Histologic and immunohistologic characterization of skin localization of myeloid disorders: a study of 173 cases. Am J Clin Pathol (2011) 1.06
Reliability of the histopathologic diagnosis of malignant melanoma in childhood. Arch Dermatol (2002) 1.02
The immunopathobiology of syphilis: the manifestations and course of syphilis are determined by the level of delayed-type hypersensitivity. Am J Dermatopathol (2011) 1.02
Extranodal NK/T-cell lymphoma: toward the identification of clinical molecular targets. J Biomed Biotechnol (2011) 1.02
From hidroacanthoma simplex to poroid hidradenoma: clinicopathologic and immunohistochemic study of poroid neoplasms and reappraisal of their histogenesis. Am J Dermatopathol (2010) 1.02
Epidermodysplasia verruciformis-associated and genital-mucosal high-risk human papillomavirus DNA are prevalent in nevus sebaceus of Jadassohn. J Am Acad Dermatol (2008) 1.01
Cutaneous Destombes-Rosai-Dorfman disease: absence of detection of HHV-6 and HHV-8 in skin. J Cutan Pathol (2002) 1.00
Active chronic sarcoidosis is characterized by increased transitional blood B cells, increased IL-10-producing regulatory B cells and high BAFF levels. PLoS One (2012) 0.98
CD158k/KIR3DL2 is a new phenotypic marker of Sezary cells: relevance for the diagnosis and follow-up of Sezary syndrome. J Invest Dermatol (2004) 0.95
MC1R, SLC45A2 and TYR genetic variants involved in melanoma susceptibility in southern European populations: results from a meta-analysis. Eur J Cancer (2012) 0.95
Molecular profiles of neurofibromatosis type 1-associated plexiform neurofibromas: identification of a gene expression signature of poor prognosis. Clin Cancer Res (2004) 0.94
A collision tumor involving Basal cell carcinoma and lentigo maligna melanoma. Am J Dermatopathol (2005) 0.94
A new spectrum of skin toxic effects associated with the multikinase inhibitor vandetanib. Arch Dermatol (2012) 0.94
Bcl-2 protein expression is the strongest independent prognostic factor of survival in primary cutaneous large B-cell lymphomas. Blood (2004) 0.93
Comparison of histopathologic-clinical characteristics of Jessner's lymphocytic infiltration of the skin and lupus erythematosus tumidus: Multicenter study of 46 cases. J Am Acad Dermatol (2007) 0.93
Brooke-Spiegler syndrome: report of 10 patients from 8 families with novel germline mutations: evidence of diverse somatic mutations in the same patient regardless of tumor type. Diagn Mol Pathol (2010) 0.93
Microarray-based identification of tenascin C and tenascin XB, genes possibly involved in tumorigenesis associated with neurofibromatosis type 1. Clin Cancer Res (2007) 0.93
Expression and function of the natural cytotoxicity receptor NKp46 on circulating malignant CD4+ T lymphocytes of Sézary syndrome patients. J Invest Dermatol (2010) 0.91
Limited efficacy and tolerance of imatinib mesylate in steroid-refractory sclerodermatous chronic GVHD. Blood (2012) 0.91
Anakinra for difficult-to-treat neutrophilic panniculitis: IL-1 blockade as a promising treatment option for neutrophil-mediated inflammatory skin disease. Dermatology (2010) 0.91
Composite tumors associating trichoblastoma and benign epidermal/follicular neoplasm: another proof of the follicular nature of inverted follicular keratosis. J Cutan Pathol (2009) 0.89
Heterogeneous abnormalities of CCND1 and RB1 in primary cutaneous T-Cell lymphomas suggesting impaired cell cycle control in disease pathogenesis. J Invest Dermatol (2006) 0.88
Efalizumab-induced bullous pemphigoid. J Am Acad Dermatol (2010) 0.88
TWEAK affects keratinocyte G2/M growth arrest and induces apoptosis through the translocation of the AIF protein to the nucleus. PLoS One (2012) 0.87
Influence of evaluation of clinical pictures on the histopathologic diagnosis of inflammatory skin disorders. J Am Acad Dermatol (2010) 0.86
CD158k/KIR3DL2 and NKp46 are frequently expressed in transformed mycosis fungoides. Exp Dermatol (2012) 0.86
Neutrophilic skin lesions in autoimmune connective tissue diseases: nine cases and a literature review. Medicine (Baltimore) (2014) 0.86
Severe aplastic anemia associated with eosinophilic fasciitis: report of 4 cases and review of the literature. Medicine (Baltimore) (2013) 0.85
Recent discoveries in the genetics of melanoma and their therapeutic implications. Arch Immunol Ther Exp (Warsz) (2007) 0.85
Vascular invasion and other invasive features in granular cell tumours of the skin: a multicentre study of 119 cases. J Clin Pathol (2013) 0.85
Antiproliferative effect of semaphorin 3F on human melanoma cell lines. J Invest Dermatol (2006) 0.85
Value of the CD8-CD3 ratio for the diagnosis of mycosis fungoides. Mod Pathol (2003) 0.85
Atypical severe immune-related adverse effects resulting from sequenced immunotherapy in melanoma. Melanoma Res (2015) 0.85
Malignant eccrine spiradenoma: a new case report. J Cutan Pathol (2009) 0.85
Characterization of CXCL13+ neoplastic t cells in cutaneous lesions of angioimmunoblastic T-cell lymphoma (AITL). Am J Surg Pathol (2007) 0.85
Inflammatory vitiligo-like macules that simulate hypopigmented mycosis fungoides. Eur J Dermatol (2003) 0.85
Cutaneous macroglobulinosis: a report of 2 cases. Arch Dermatol (2010) 0.84
Unusual presentations of lung cancer: Case 3. Paraneoplastic digital necrosis in a patient with small-cell lung cancer. J Clin Oncol (2002) 0.84
In vivo multiphoton imaging of human skin: assessment of topical corticosteroid-induced epidermis atrophy and depigmentation. J Biomed Opt (2012) 0.84
Inducible expression and pathophysiologic functions of T-plastin in cutaneous T-cell lymphoma. Blood (2012) 0.84
Borrelia burgdorferi-associated lymphocytoma cutis simulating a primary cutaneous large B-cell lymphoma. J Am Acad Dermatol (2002) 0.84
Identification of a novel CD160+ CD4+ T-lymphocyte subset in the skin: a possible role for CD160 in skin inflammation. J Invest Dermatol (2007) 0.83
[A palpebral tumor]. Ann Pathol (2006) 0.83
Dendritic cells in the skin--potential use for melanoma treatment. Pigment Cell Melanoma Res (2008) 0.83
Allogeneic stem cell transplantation for advanced cutaneous T-cell lymphomas: a study from the French Society of Bone Marrow Transplantation and French Study Group on Cutaneous Lymphomas. Haematologica (2013) 0.83
Immunosuppressive therapy in dermatology and PML. J Dtsch Dermatol Ges (2009) 0.83
Livedoid and necrotic skin lesions due to intra-arterial buprenorphine injections evidenced by maltese cross-shaped histologic bodies. Arch Dermatol (2010) 0.83
Skin tumors with matrical differentiation: lessons from hair keratins, beta-catenin and PHLDA-1 expression. J Cutan Pathol (2014) 0.82
Primary cutaneous cribriform carcinoma: a rare apocrine tumour. J Cutan Pathol (2005) 0.82
Anti-PD1-induced collagenous colitis in a melanoma patient. Melanoma Res (2016) 0.82